In China, the enrolment rate of single-country trials far exceeds that of multinational trials in every phase (Figure 1). GlobalData looked at trials between January 2001 and April 2018 and found the rate was 12 times higher in single-country trials in Phase II and seven times higher in Phase I and Phase III trials. The much higher enrolment rate in single-country trials can be attributed to the single regulatory and ethical authority, as well as the availability of subjects meeting the inclusion criteria for trials.

Figure 1: Enrolment rate by phase in multinational and single-country trials in China

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.
Source: GlobalData                                                                                                                                                                                                    ©GlobalData